Congressmen demand faster publication of trial data after BMJ revealed long delays

BMJ 2012; 344 doi: (Published 20 February 2012) Cite this as: BMJ 2012;344:e1217
  1. Bob Roehr
  1. 1Washington, DC

Three members of the US House of Representatives have written to the National Institutes of Health and the Food and Drug Administration expressing concern that the results of clinical studies are not being published in a timely manner, as prescribed by law, after widespread delays to publication were highlighted in the BMJ.

“Researchers and pharmaceutical companies routinely fail to publish data from clinical drug trials in a timely fashion,” they wrote, citing a BMJ research paper that appeared earlier this year (BMJ 2012;344:d7373, doi:10.1136/bmj.d7373). “This study raises concerns about whether the FDA is adequately enforcing the law requiring …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial